Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvid Edén

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Neurology|September 7, 2021
Author Response: CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case SeriesArvid Edén
The Journal of Infectious Diseases|November 30, 2023
Reply to FinstererNelly Kanberg, Michael Schöll, Arvid Edén, et al.
Journal of Neurochemistry|June 25, 2021
Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesisArvid Edén, Joel Simrén, Richard W Price, et al.
Acta Neurologica Scandinavica|April 26, 2022
Blood biomarkers for HIV infection with focus on neurologic complications-A reviewLars Hagberg, Arvid Edén, Henrik Zetterberg, et al.
Journal of Internal Medicine|November 29, 2022
Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIVEnrico Ripamonti, Arvid Edén, Staffan Nilsson, et al.
The Journal of Infectious Diseases|January 15, 2008
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapyArvid Edén, Richard W Price, Serena Spudich, et al.
Clinical Chemistry and Laboratory Medicine|April 2, 2024
IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosisLars Hagberg, Igal Rosenstein, Jan Lycke, et al.
The Journal of Infectious Diseases|September 30, 2016
Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal StudyArvid Edén, Staffan Nilsson, Lars Hagberg, et al.
Open Forum Infectious Diseases|March 2, 2023
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV InfectionArvid Edén, Frida Rydberg, Aylin Yilmaz, et al.
The Journal of Infectious Diseases|November 6, 2010
HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatmentArvid Edén, Dietmar Fuchs, Lars Hagberg, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Neurology|September 7, 2021
Author Response: CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case SeriesArvid Edén
The Journal of Infectious Diseases|November 30, 2023
Reply to FinstererNelly Kanberg, Michael Schöll, Arvid Edén, et al.
Journal of Neurochemistry|June 25, 2021
Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesisArvid Edén, Joel Simrén, Richard W Price, et al.
Acta Neurologica Scandinavica|April 26, 2022
Blood biomarkers for HIV infection with focus on neurologic complications-A reviewLars Hagberg, Arvid Edén, Henrik Zetterberg, et al.
Journal of Internal Medicine|November 29, 2022
Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIVEnrico Ripamonti, Arvid Edén, Staffan Nilsson, et al.
The Journal of Infectious Diseases|January 15, 2008
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapyArvid Edén, Richard W Price, Serena Spudich, et al.
Clinical Chemistry and Laboratory Medicine|April 2, 2024
IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosisLars Hagberg, Igal Rosenstein, Jan Lycke, et al.
The Journal of Infectious Diseases|September 30, 2016
Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal StudyArvid Edén, Staffan Nilsson, Lars Hagberg, et al.
Open Forum Infectious Diseases|March 2, 2023
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV InfectionArvid Edén, Frida Rydberg, Aylin Yilmaz, et al.
The Journal of Infectious Diseases|November 6, 2010
HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatmentArvid Edén, Dietmar Fuchs, Lars Hagberg, et al.
Pageof 3